Alfred L. Fatale III



Alfred L. Fatale III is a Partner in the New York office of Labaton Sucharow LLP and currently leads a team of attorneys focused on litigating securities claims arising from initial public offerings, secondary offerings, and stock-for-stock mergers. 

Alfred's success in moving the needle in the legal industry has earned him recognition from the National Law Journal as a "Plaintiffs’ Lawyer Trailblazer" and The American Lawyer as a "Northeast Trailblazer." 

Alfred represents individual and institutional investors in cases related to the protection of the financial markets and public securities offerings in trial and appellate courts throughout the country.  In particular, he is leading the Firm’s efforts to litigate securities claims against several companies in state courts following the U.S. Supreme Court’s decision in Cyan, Inc. v. Beaver County Employees Retirement Fund.  This includes prosecuting such claims against Lyft, CVS, Restaurant Brands International, Venator Materials PLC, and SciPlay Corporation.

Since joining the Firm in 2016, Alfred has lead the investigation and prosecution of several successful cases, including In re ADT Inc. Securities Litigation, resulting in a $30 million recovery; In re CPI Card Group Inc. Securities Litigation, resulting in a $11 million recovery; In re BrightView Holdings, Inc. Securities Litigation, resulting in a $11.5 million recovery; and Plymouth County Retirement Association v. Spectrum Brands Holdings Inc., resulting in a $9 million recovery.  Alfred’s recoveries include obtaining more than $50 million for investors in cases litigated in state courts.

Alfred also regularly represents investors in cases alleging fraud-related conduct.  Alfred is actively involved in Murphy v. Precision Castparts Corp., a case against a major aerospace parts manufacturer that allegedly misled investors about its market share and demand for its products, and Boston Retirement System v. Alexion Pharmaceuticals Inc., a class action arising from the company’s conduct in connection with sales of Soliris—a drug that costs between $500,000 and $700,000 a year.

Prior to joining Labaton Sucharow, Alfred was an Associate at Fried, Frank, Harris, Shriver & Jacobson LLP, where he advised and represented financial institutions, investors, officers, and directors in a broad range of complex disputes and litigations including cases involving violations of federal securities law and business torts.

Alfred is an active member of the American Bar Association and the New York City Bar Association.

Alfred earned his Juris Doctor from Cornell Law School, where he was a member of the Cornell Law Review as well as the Moot Court Board.  He also served as a Judicial Extern under the Honorable Robert C. Mulvey.  He received his bachelor's degree, summa cum laude, from Montclair State University.


2008, New York

U.S. Court of Appeals
2011, Second Circuit

U.S. District Court
2009, Southern District of New York
2009, Eastern District of New York
2019, Western District of New York